Naveen Yarlagadda Selected Research

Neoplasms (Cancer)

1/2020

Nivolumab-induced immune-mediated neurotoxicity in Hodgkin lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naveen Yarlagadda Research Topics

Disease

2	Multiple Myeloma 01/2022 - 11/2021
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2018
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2022
1	Residual Neoplasm 01/2022
1	Dysarthria (Spastic Dysarthria) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Hodgkin Disease (Hodgkin's Disease) 01/2020
1	Deglutition Disorders (Dysphagia) 01/2020
1	Kidney Neoplasms (Kidney Cancer) 05/2014
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2014
1	Neoplasm Metastasis (Metastasis) 08/2013
1	Prostatic Neoplasms (Prostate Cancer) 08/2013

Drug/Important Bio-Agent (IBA)

2	Monoclonal AntibodiesIBA 11/2021 - 01/2020
2	NivolumabIBA 01/2020 - 01/2020
1	ADP-ribosyl Cyclase 1IBA 11/2021
1	pembrolizumabIBA 01/2020
1	IpilimumabIBA 01/2020
1	encorafenibIBA 01/2018
1	binimetinibIBA 01/2018
1	cobimetinibIBA 01/2018
1	dabrafenibIBA 01/2018
1	trametinibIBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	VemurafenibIBA 01/2018
1	Interleukin-2 (IL2)IBA 05/2014
1	Docetaxel (Taxotere)FDA Link 08/2013
1	cabazitaxel FDA Link 08/2013
1	Prednisone (Sone)FDA LinkGeneric 08/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2013

Therapy/Procedure

3	Therapeutics 11/2021 - 05/2014
2	Drug Therapy (Chemotherapy) 01/2020 - 08/2013
1	Stem Cell Transplantation 01/2022
1	Aftercare (After-Treatment) 01/2022
1	Transplantation 01/2022
1	Immunotherapy 01/2020
1	Nephrectomy 05/2014
1	Castration 08/2013